Schedule 13G ownership disclosure
RXI PHARMACEUTICALS CORP
Security class unavailable · CUSIP: 74979C303
Event date: 2017-01-06
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001575872-17-000024
- Form type
- SC 13G
- Filer
- Phio Pharmaceuticals Corp.
- CIK
- CIK 1533040
- Filed
- Feb 14, 2017
- Reporting period
- Jan 06, 2017
- Description
- Schedule 13G beneficial ownership